Release Date: 11/02/14 14:13 Summary: Notice of status of defeating conditions Price Sensitive: No Download Document 228.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%